OSE Immunotherapeutics SA (OSE.PA)
EUR 7.17
(-1.38%)
EUR 7.17
(-1.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.22 Million | 18.3 Million | 26.3 Million | 10.41 Million | 25.95 Million | 24.45 Million |
| Cost of Revenue | - | - | - | -1000.00 | 8000.00 | 4000.00 |
| Gross Profit | 2.22 Million | 18.3 Million | 26.3 Million | 10.41 Million | 25.94 Million | 24.45 Million |
| Operating Expenses | 23.58 Million | 38.78 Million | 45.67 Million | 34.42 Million | 30.53 Million | 19.59 Million |
| Selling, General and Administrative Expenses | 68 Thousand | 8.8 Million | 11.57 Million | 6.58 Million | 5.44 Million | 4.39 Million |
| Research and Development Expenses | 24.21 Million | 29.9 Million | 33.96 Million | 27.84 Million | 25.09 Million | 19.69 Million |
| Other Expenses | - | -78 Thousand | -134 Thousand | - | - | -27 Thousand |
| Cost and Expenses | 23.58 Million | 42.33 Million | 48.27 Million | 35.15 Million | 31.01 Million | 19.59 Million |
| Operating Income | -22.98 Million | -24.03 Million | -21.97 Million | -24.73 Million | -5.06 Million | 4.84 Million |
| Interest Expense | 2.26 Million | 1.37 Million | 836 Thousand | 273 Thousand | 181 Thousand | 100 Thousand |
| Income Tax Expense | 219 Thousand | -5.69 Million | -4.7 Million | -7.81 Million | 129 Thousand | 783 Thousand |
| Earnings before Tax | -23.22 Million | -23.45 Million | -21.55 Million | -24.36 Million | -4.52 Million | 4.7 Million |
| Net Income | -23 Million | -17.76 Million | -16.85 Million | -16.55 Million | -4.65 Million | 5.49 Million |
| Earnings Per Share Basic | -1.18 | -0.96 | -0.93 | -1.06 | -0.31 | 0.35 |
| Earnings Per Share Diluted | -1.18 | -0.96 | -0.93 | -1.06 | -0.31 | 0.35 |
| Weighted Average Shares Outstanding | 19.56 Million | 18.45 Million | 18.15 Million | 15.55 Million | 14.89 Million | 15.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.56 Million | 18.45 Million | 18.15 Million | 15.55 Million | 14.89 Million | 15.51 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -10.45 | -1.12 | -0.74 | -2.30 | -0.18 | 0.20 |
| Profit Margin | -10.33 | -0.97 | -0.64 | -1.59 | -0.18 | 0.22 |
| EBITDA | -23.26 Million | -15.68 Million | -14.65 Million | -18.71 Million | -1.24 Million | 536 Thousand |
| Earnings Before Tax Margin | -10.32 | -1.31 | -0.84 | -2.37 | -0.20 | 0.20 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 69.04 Million | 2.22 Million | 869 Thousand | 1.35 Million | 18.3 Million | 2.25 Million |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 69.04 Million | 2.22 Million | 869 Thousand | 1.35 Million | 18.3 Million | 2.25 Million |
| Operating Expenses | 21.25 Million | 31.11 Million | 11.23 Million | 18.73 Million | 38.78 Million | 17.73 Million |
| Selling, General and Administrative Expenses | 5.19 Million | - | 2.86 Million | 4.3 Million | - | 4.2 Million |
| Research and Development Expenses | 16.06 Million | - | 17.2 Million | 14.42 Million | - | 13.5 Million |
| Other Expenses | - | - | - | - | -78 Thousand | -29 Thousand |
| Cost and Expenses | 22.91 Million | 34.58 Million | 11.23 Million | 20.56 Million | 42.33 Million | 19.5 Million |
| Operating Income | 46.12 Million | -32.35 Million | -9.48 Million | -19.2 Million | -24.03 Million | -17.25 Million |
| Interest Expense | 1.86 Million | 2.19 Million | 1.36 Million | 1.05 Million | 1.37 Million | 711 Thousand |
| Income Tax Expense | -67 Thousand | -6 Million | 135 Thousand | -2.53 Million | -5.69 Million | -2.5 Million |
| Earnings before Tax | 57.1 Million | -29 Million | -11.27 Million | -14.39 Million | -23.45 Million | -18.28 Million |
| Net Income | 57.17 Million | -23 Million | -11.14 Million | -11.86 Million | -17.76 Million | -15.78 Million |
| Earnings Per Share Basic | 2.63 | - | -0.54 | -0.64 | - | -0.86 |
| Earnings Per Share Diluted | 2.63 | - | -0.54 | -0.64 | - | -0.86 |
| Weighted Average Shares Outstanding | 21.75 Million | 19.56 Million | 20.46 Million | 18.62 Million | 18.45 Million | 18.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.75 Million | 19.56 Million | 20.49 Million | 18.62 Million | 18.45 Million | 18.45 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | 0.88 | - | -10.71 | -12.79 | - | -6.86 |
| Profit Margin | 0.83 | -10.33 | -12.82 | -8.73 | -0.97 | -7.00 |
| EBITDA | 60.63 Million | - | -9.3 Million | -17.37 Million | - | -15.48 Million |
| Earnings Before Tax Margin | 0.67 | -14.53 | -10.91 | -14.14 | -1.31 | -7.65 |
CHECKPOINT
KCC
6258
300760
KREN
1410